3 Results for "

fibrodysplasia ossificans progressive

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "fibrodysplasia ossificans progressive" in MCE Product Catalog:

2
2 Cited Publications
Cat. No.: HY-15897
CAS No.: 1432597-26-6
Purity:  99.70%
Target:  

TGF-β Receptor

Research Areas:  

Cancer

LDN-212854 is a bone morphogenetic protein (BMP) inhibitor that potently inhibits ALK2 (IC50: 1.3 nM). LDN-212854 also inhibits ALK1 (IC50: 2.40 nM). LDN-212854 can be used in the research of fibrodysplasia ossificans progressive and cancers, such as hepatocellular carcinoma (HCC) .
loading...
    loading...
Cat. No.: HY-148234
CAS No.: 2421141-51-5
Purity:  98.71%
Research Areas:  

Cancer

M4K2234, a chemical probe, is an orally active, highly selective inhibitor of ALK1 and ALK2 with IC50 values of 7 nM and 14 nM, respectively. M4K2234 specifically blocks BMP signaling by inhibiting the phosphorylation of SMAD1/5/8. M4K2234 inhibits BMP7-stimulated reporter gene activity (IC50 = 16 nM). M4K2234 can be used for the investigation of ALK1/2-mediated biological processes and related diseases such as diffuse midline glioma (DMG) and fibrodysplasia ossificans progressiva (FOP) .
loading...
    loading...
Cat. No.: HY-17661
CAS No.: 1062368-55-1
Synonyms: Depiperazine-LDN-193189
Research Areas:  

Cancer

Depiperazine-DM3189 is a derivative of LDN193189 (HY-12071). LDN193189 is a potent selective BMP type I receptor (BMP I) inhibitor. LDN-193189 efficiently inhibits transcriptional activity of the BMP type I receptors ALK2 and ALK3 with IC50 values of 5 nM and 30 nM, respectively. LDN-193189 can be used for the research of bone morphogenetic protein signalling, such as fibrodysplasia ossificans progressiva .
loading...
    loading...